Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Connect Biopharma Holdings Limited Sponsored ADR (CNTB : NSDQ)

• Company Description    Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from our T cell-driven research. The company's product candidate includes CBP-201. Connect Biopharma Holdings Limited is based in TAICANG, China. Number of Employees: 62

• Price / Volume Information    Yesterday's Closing Price: $1.56 Daily Weekly Monthly 20 Day Moving Average: 149,569 shares Shares Outstanding: 55.72 (millions) Market Capitalization: $86.93 (millions) Beta: -0.09 52 Week High: $2.86 52 Week Low: $0.51 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -27.44% -28.72% 12 Week 55.98% 41.69% Year To Date 13.04% 5.46%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3580 CARMEL MOUNTAIN ROAD SUITE 200 - SAN DIEGO,CA 92130 USA ph: 877-245-2787 fax: +1 8586147007 alex.lobo@precisionaq.com http://www.connectbiopharm.com

• General Corporate Information    Officers Barry D. Quart - Chief Executive Officer and Director Kleanthis G. Xanthopoulos - Chairman Lisa Peraza - Vice President; Finance Kan Chen - Director James Z. Huang - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: G23549101 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: - Share - Related Items Shares Outstanding: 55.72 Most Recent Split Date: (:1) Beta: -0.09 Market Capitalization: $86.93 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.24 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.91 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.21 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -21.05% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - 7.24 03/31/25 - 10.25 12/31/24 - 11.46 Quick Ratio 06/30/25 - 7.24 03/31/25 - 10.25 12/31/24 - 11.46 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -59.17 Book Value 06/30/25 - 1.28 03/31/25 - 1.50 12/31/24 - 1.67 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - 0.01 03/31/25 - 0.01 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.72 03/31/25 - 0.71 12/31/24 - 0.03

Powered by Zacks Investment Research ©